Description
OTHER FUNCTIONS- FLU VACCINE
First action · last action
2012-06-12 · 2013-05-23
Transactions
2
First transaction's obligation
$3,884
Base + all options value (sum of deltas)
$3,705
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
VA797P12C0020
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2012-06-12+$3,884= $3,884
- Mod P000012013-05-23-$179= $3,705
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2012-06-12 | +$3,884 | $3,884 | OTHER FUNCTIONS- FLU VACCINE |
| Mod P00001· FUNDING ONLY ACTION | 2013-05-23 | −$179 | $3,705 | OTHER FUNCTIONS- FLU VACCINE |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI NCXBGGQ8YTU9)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24626N0644 | 246-NETWORK CONTRACTING OFFICE 6 (36C246) · 6505 · DRUGS AND BIOLOGICALS | $24,097 | FY2026 |
| 36C26026N0269 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $19,614 | FY2026 |
| 36C24526N0396 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $31,943 | FY2026 |
| 36C24526N0408 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $20,735 | FY2026 |
| 36C24526N0416 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $29,421 | FY2026 |
| 36C24526N0426 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $70,050 | FY2026 |
Other recipients under 6505 from 542-COATESVILLE (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA24414J1978 | SEQIRUS USA INC | 542-COATESVILLE | $46,325 | FY2014 |
| VA24413J3283 | SEQIRUS USA INC | 542-COATESVILLE | $46,325 | FY2013 |
| VA24412J1924 | NOVARTIS VACCINES AND DIAGNOSTICS, INC. | 542-COATESVILLE | $46,665 | FY2012 |
| VA24412J1319 | BAYER CORPORATION | 542-COATESVILLE | $3,431 | FY2012 |
| VA24412F0721 | BAYER CORPORATION | 542-COATESVILLE | $3,431 | FY2012 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24412J1923_3600_VA797P12C0020_3600 · retrieved 2026-09-26.